CoChat

Isotretinoin versus placebo in the treatment of cystic acne

Peck, Gary L., Olsen, Thomas G., Butkus, Danute, Pandya, Mangala, Arnaud-Battandier, Jeanine, Gross, Earl G., Windhorst, Dorothy B., Cheripko, Joyce · 1982 · Journal of the American Academy of Dermatology

The DOI matches its Crossref record, with a small difference in title or year; 18 of the 21 references it cites were found in a registry or an index.

Abstract

Thirty-three patients with treatment-resistant cystic and conglobate acne entered a randomized, double-blind protocol testing the efficacy of isotretinoin versus placebo. There was an overall 57% increase in the number of cystic lesions in seventeen patients who initially received placebo. Sixteen of these seventeen patients then received isotretinoin, with a resultant 98% improvement. The sixteen patients who had been randomly assigned to receive initial therapy with isotretinoin had a 95% improvement. Twenty-seven of the thirty-two patients treated with isotretinoin cleared completely. The average maximum dosage of isotretinoin received by these patients was 1.2 mg/kg/day. Eighteen patients received only one 4-month course of isotretinoin. Fifteen patients received two courses. These included twelve patients with predominantly truncal acne who responded partially to the first course, and three patients who had cleared completely after one course of therapy but had mild relapses after an average of six months off of treatment. All patients are now in remission averaging 38 months in duration. Skin biopsies and quantitative measurement of sebum production during therapy indicated a profound inhibition of sebaceous gland size and function, which may be central to the mechanism of action of isotretinoin in acne.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0190-9622(82)70063-5

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 18 references

Research works printed but not linked: 1

  1. Glynn, 1980, Changes in cholesterol and triglycerides as predictors of ischernic heart disease in men, Clin Res, 28, 474

Cited by

See all 179

Metadata

Authors
Peck, G. L., Olsen, T. G., Butkus, D., Pandya, M., Arnaud-Battandier, J., Gross, E. G., Windhorst, D. B., & Cheripko, J.
Affiliations
National Institutes of Health (US)
Corresponding author
Peck, Gary L.
Venue
Journal of the American Academy of Dermatology
Publisher
Elsevier BV
Published
1982-04
Volume
6
Issue
4
Pages
735-745
ISSN
0190-9622 (ISSN-L)
OpenAlex
W1535533273
Cited by
179
References
21
Citations by year
2026: 1 · 2025: 3 · 2024: 4 · 2023: 1 · 2022: 1 · 2021: 3 · 2020: 6 · 2019: 7 · 2018: 1 · 2017: 6 · 2016: 4 · 2015: 5 · 2014: 4 · 2013: 5 · 2012: 5
FWCI
27.15
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Locations
  • Journal of the American Academy of Dermatology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Dermatology › Acne and Rosacea Treatments and Effects
  • Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
  • Health Sciences › Medicine › Dermatology › Dermatologic Treatments and Research
Keywords
isotretinoin, cystic acne, treatment-resistant acne, sebum production, relapse, truncal acne
MeSH terms
Acne Vulgaris, Adolescent, Adult, Clinical Trials as Topic, Double-Blind Method, Female, Humans, Isomerism, Male, Sebum, Tretinoin, Isotretinoin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Isotretinoin versus placebo in the treatment of cystic acne. https://app.cochat.ai/papers/10.1016/s0190-9622(82)70063-5
The paper
Peck, G. L., Olsen, T. G., Butkus, D., Pandya, M., Arnaud-Battandier, J., Gross, E. G., Windhorst, D. B., & Cheripko, J. (1982). Isotretinoin versus placebo in the treatment of cystic acne. Journal of the American Academy of Dermatology. https://doi.org/10.1016/s0190-9622(82)70063-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.